Timing of androgen deprivation therapy for prostate cancer patients after radiation: Planned combined analysis of two randomized phase 3 trials.

Andrew Loblaw,Julie K. Bassett,Catherine D'Este,Gregory R. Pond,P. Cheung,Jeremy Laurence Millar,Mark Frydenberg,Madeleine Trudy King,Himu Lukka,S. Malone,Roger L. Milne,Tom Pickles,Rosemary Smith,Martin R. Stockler,Sandra Turner,Keen Hun Tai,Henry H. Woo,Gillian Duchesne

Timing of androgen deprivation therapy for prostate cancer patients after radiation: Planned combined analysis of two randomized phase 3 trials.

2018

Andrew Loblaw
Julie K. Bassett
Catherine D'Este
Gregory R. Pond
P. Cheung
Jeremy Laurence Millar
Mark Frydenberg
Madeleine Trudy King
Himu Lukka
S. Malone
Roger L. Milne
Tom Pickles
Rosemary Smith
Martin R. Stockler
Sandra Turner
Keen Hun Tai
Henry H. Woo
Gillian Duchesne

5018Background: The TOAD (TROG 03.06; NCT00110162) phase 3 randomized trial showed that immediate androgen deprivation therapy (IADT) improved overall survival (OS) and time to clinical progression...

Keywords:

Prostate cancer
Androgen deprivation therapy
Radiation
Physical therapy
Cancer research
Medicine
Randomized controlled trial
Oncology
overall survival
Internal medicine
clinical progression
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations